Monday 19 October 2026
Export FEED’s income statement to Excel — free account
ENvue Medical, Inc.
FEED Healthcare Medical Devices
ENvue Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 million, roughly unchanged from fiscal 2024. In the quarter to June 2026, revenue fell 51.6%, EPS grew 75.8%, free cash flow grew 19.8% and total debt fell 45.3%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.37
0.12
−24.49%
Follow FEED
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
2 | 3 | 2 | 2 |
+8 more TTM periods Free account |
| (138.10%) | (110.87%) | (98.32%) | (20.67%) | ||
| (109.44%) | (89.37%) | (74.97%) | (15.52%) | ||
ROIC |
(53.44%) | (50.17%) | (47.18%) | (16.16%) | |
Return on Tangible Assets |
2,100.26% | 6,936.04% | (2,297.95%) | 304.52% | |
Average Days of Receivables |
38.85 | 55.56 | 41.32 | 34.26 | |
Free Cash Flow per Share |
(22.90) | (45.30) | (180.34) | (101.83) | |
Free Cash Flow |
(11.74) | (12.41) | (9.43) | (7.28) | |
Capital Expenditures |
(0.09) | (0.07) | (0.06) | (0.04) | |
| Other line items | |||||
Cash ROIC |
(35.61%) | (35.10%) | (24.29%) | (14.42%) | |
Accounts Receivable Turnover |
12.04 | 6.32 | 13.19 | 6.45 | |
Accounts Payable Turnover |
0.59 | 0.64 | 1.33 | 0.52 | |
Inventory Turnover |
1.01 | 1.14 | 1.06 | 0.84 | |
Average Days of Payables |
562.83 | 506.86 | 465.98 | 924.45 | |
Days of Inventory on Hand |
388.00 | 337.31 | 355.42 | 435.71 | |
Tax Rate |
(0.02) | (0.01) | (0.02) | 0.02 | |
Research and Development Expense of Revenue |
61.99% | 77.95% | 69.02% | 78.92% | |
Selling, General and Administrative Expense of Revenue |
695.53% | 532.92% | 396.63% | 302.87% | |
Share Based Compensation of Revenue |
106.33% | 0.00% | 0.00% | 7.11% | |
Interest Coverage |
5.43 | 5.72 | 5.21 | 3.38 | |
Operating CF/Net income |
0.24 | 0.33 | 0.56 | 1.58 | |
Depreciation/Fixed assets |
83.48 | 96.46 | 101.27 | 5.15 | |
Capex/Depreciation |
(0.01) | (0.01) | 0.00 | (0.06) | |
Revenue per Share |
3.76 | 7.96 | 48.81 | 37.55 | |
Operating CF per Share |
(22.71) | (45.04) | (179.20) | (101.31) | |
Capex per Share |
(0.19) | (0.26) | (1.15) | (0.52) | |
Capex to Sales |
0.05 | 0.03 | 0.02 | 0.01 |
Columns are period end dates